Corcept Therapeutics Incorporated
Status: Publicly traded
Direct answer
Corcept Therapeutics Incorporated is publicly traded on NASDAQ under the ticker CORT.
Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States. Its primary commercial offering is Korlym (mifepristone) tablets, an oral medication taken once daily. Korlym is prescribed for...
Can you invest in Corcept Therapeutics Incorporated?
Yes. Corcept Therapeutics Incorporated is publicly traded on NASDAQ under the ticker CORT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Corcept Therapeutics Incorporated
Detailed equity research is provided by MarketSnap.